Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06452537 |
| Consolidated Lead Sponsor | Tianjin Medical University General Hospital |
| Therapeutic Condition Cohort | Rare Genetic, Women's Health, and Other |
| Clinical Trial Phase | Phase II/III |
| Overall Recruitment Status | ACTIVE NOT RECRUITING |
| Registered Enrollment | 102 participants (ESTIMATED) |
| Registered Start Date | 2024-07-09 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Anhui Provincial Hospital | Hefei, China | Open Hospital Dossier -> |
| The Second Hospital of Hebei Medical University | Shijiazhuang, China | Open Hospital Dossier -> |
| General Hospital of Ningxia Medical University | Yinchuan, China | Open Hospital Dossier -> |
| First Hospital of Shanxi Medical University | Taiyuan, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.